In AI firm's detailed threat intel report: five biology cases involving state-linked scientists, operations across cyber, ...

Cancer biology and, in turn, cancer treatment have come a long way in the last few decades. Most people recognize this ...

AI can rapidly generate new protein binders, but wet-lab validation remains a major bottleneck. Combining cell-free protein ...

The University of California, Davis (UC Davis) is recruiting dogs with suspected or confirmed glioma for 2 clinical trials ...

Unlike an animal cell, a plant cell can't crawl or migrate. It's locked inside a rigid wall, cemented to its neighbors for ...

Brain tumors develop within an organ that changes substantially with age. A new review in Ageing and Cancer Research & ...

Cells have all kinds of intricate machinery to control genes, switching them on and off at the right times and under the ...

Global Voices in Renal Oncology, Day 1 / Abhinav Sidana, Access to cancer care, Adjuvant Therapy, Advanced RCC, Ahmed Elalfy, ...

As longevity clinics multiply and Muse cell branding proliferates, the questions patients aren't asking could cost them more than money.

Advances in media optimization, cell engineering, and AI are reshaping intensified bioprocessing for higher productivity, better quality, and greater manufacturing efficiency.

Second clinical-stage asset generated from the company’s proprietary library of SIRP-targeted antibodiesSOUTH SAN FRANCISCO, ...

The global organoid intelligence market is projected to grow from USD 78.6 million in 2026 to USD 865.3 million by 2036, at a 27.1% CAGR. Growth is driven by advances in brain organoids, biological ...